SANA 241220 2.50C (SANA241220C2500) Stock Options, News & Quotes

US OptionsDetailed Quotes

SANA241220C2500

Watchlist

0.39
-0.06-13.33%

15min DelayClose Nov 25 16:00 ET

0.41High0.39Low

Intraday

5D
Daily

News

Sana Biotechnology to Present at December 2024 Investor Conferences
GlobeNewswire16:05 ET
Flagship Pioneering Announces Two New Agreements With Ampersand Biomedicines and Montai Therapeutics Under Its Strategic Partnership With Pfizer
PR NewswireNov 20 06:30 ET
Down -24.69% in 4 Weeks, Here's Why Sana (SANA) Looks Ripe for a Turnaround
Zacks Nov 11 08:40 ET
Sana Biotechnology Analyst Ratings
BenzingaNov 11 05:45 ET · Ratings
JMP Securities Maintains Sana Biotechnology(SANA.US) With Hold Rating
Moomoo NewsNov 11 00:32 ET · Ratings
TD Cowen Maintains Sana Biotechnology(SANA.US) With Hold Rating
Moomoo NewsNov 8 15:31 ET · Ratings

Comments

frankinglily

May 14 03:38

How does the biotech ecosystem support advancements in personalized medicine & genomics?
• Editing Genes | $CRISPR Therapeutics (CRSP.US)$ , $Intellia Therapeutics (NTLA.US)$ , $Beam Therapeutics (BEAM.US)$ , $Verve Therapeutics (VERV.US)$ , $Editas Medicine (EDIT.US)$
• Creating Therapies | $Prime Medicine (PRME.US)$ , $Sana Biotechnology (SANA.US)$
• Building DNA | $Twist Bioscience (TWST.US)$ , $Ginkgo Bioworks (DNA.US)$ , $Pacific Biosciences of California (PACB.US)$ , $Illumina (ILMN.US)$
• Dis...

Sturgeons and Stocks

Jan 10 20:29

$Sana Biotechnology (SANA.US)$

Moomoo AI

Dec 30, 2023 06:24

Sana Biotechnology's cash burn versus its market cap is worrisome. Despite a notable decrease in its cash burn, the potential need for more funding via new shares could result in costly shareholder dilution.

Will Sana Biotechnology (NASDAQ:SANA) Spend Its Cash Wisely?

Rivera

Apr 13, 2023 13:40

Caming up

$Sana Biotechnology (SANA.US)$

Moomoo Breakfast US

Jun 2, 2022 07:27

Columns Today's pre-market stock movers: CHWY, PATH, SNAP, HPE and more

Gainers:
• $Repare Therapeutics (RPTX.US)$ +26.4% (announces worldwide license and collaboration agreement with Roche for camonsertib)
• $Chewy (CHWY.US)$+19.8% (Chewy stock soars on earnings. Here's what really mattered)
• $UiPath (PATH.US)$ +11.7% ( reported first-quarter revenue growth of 32% year-over-year to $245.1 million)
• $Pure Storage (PSTG.US)$ +10.6% (In reaction to earnings)
• $Credo Technology (CRDO.US)$ +10.2% (In reaction ...